These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2893419)

  • 21. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A; Kulkarni SK
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB; Jackson DM; Wallis EM; Edwards SR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM; Waddington JL
    Pharmacol Biochem Behav; 1990 Jan; 35(1):105-10. PubMed ID: 1969161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.
    Mashurano M; Waddington JL
    Neuropharmacology; 1986 Aug; 25(8):947-9. PubMed ID: 3490631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM; Hashizume M
    Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.
    Molloy AG; O'Boyle KM; Pugh MT; Waddington JL
    Pharmacol Biochem Behav; 1986 Jul; 25(1):249-53. PubMed ID: 3529126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1989 Feb; 160(3):377-84. PubMed ID: 2565818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
    Andersen PH; Nielsen EB; Scheel-Krüger J; Jansen JA; Hohlweg R
    Eur J Pharmacol; 1987 Jun; 137(2-3):291-2. PubMed ID: 2956116
    [No Abstract]   [Full Text] [Related]  

  • 32. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
    Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.
    Andén NE; Grabowska-Andén M
    J Neural Transm Gen Sect; 1990; 79(3):209-14. PubMed ID: 2136999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.
    Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1984; 82(4):409-10. PubMed ID: 6427836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1985 Nov; 117(3):381-5. PubMed ID: 3878300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS; Starr MS; Kilpatrick IC
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques.
    Arnt J; Hyttel J
    J Neural Transm Gen Sect; 1990; 80(1):33-50. PubMed ID: 2137705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anorectic effect of SK & F 38393, a new dopamine agonist in rats.
    Girdhar A; Sharma DC; Sachdev KS
    Indian J Physiol Pharmacol; 1982; 26(4):317-20. PubMed ID: 6984016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
    Arnt J
    Life Sci; 1985 Aug; 37(8):717-23. PubMed ID: 3927097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.